Description/achievement of initiative
State-of-the-art biomedical research institute for tropical diseases. Objective is to develop novel compounds and find partners for clinical development, manufacturing, marketing and distribution. No profit from poor people in developing countries, but potential for profitable operations in developed markets (re-financing the research costs). Initial focus on Dengue-fever and treatment-resistant tuberculosis.
Implementation methodologies
Arrangements for Capacity-Building and Technology Transfer
Coordination mechanisms/governance structure
Partner(s)
Governments:
Government of Singapore - Singapore Economic Development Board
Major Groups:
Novartis (Switzerland)
Medecins sans Frontieres ()
various ()
Other intergovernmental organizations:
WHO (Switzerland)
Time-frame: - 2012-04-03
